UAE Launches Gene Therapy for Autism Treatment

 



The United Arab Emirates has launched two pioneering gene therapy initiatives aimed at treating autism and rare neurogenetic brain disorders in children. Led by Emirates Health Services, the projects mark a shift from symptom-based management to precision medicine that targets the genetic roots of disease. The move positions the UAE at the forefront of advanced paediatric neurological care in the region.

Targeting Genetic Causes of Autism

One of the projects focuses on genetic mutations linked to autism and epilepsy. It is being developed in collaboration with Children’s Hospital of Philadelphia, a globally recognised centre for paediatric research. Scientists aim to develop enhanced gene delivery systems capable of targeting specific brain cells with greater accuracy.

The approach seeks to improve treatment effectiveness, reduce dosage requirements and lower long-term costs. Among the conditions included is Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a rare disorder that begins with developmental delays and seizures before progressing to severe cognitive and motor decline. By intervening at the molecular level, researchers hope to alter disease trajectories rather than merely manage symptoms.

Advanced Research for Neurodegenerative Disorders

The second initiative concentrates on rare neurodegenerative diseases. Researchers will explore gene repair strategies, cell-based disease models and biomarker identification to monitor progression and treatment response. Artificial intelligence tools will analyse genomic data to refine diagnosis and identify high-risk children earlier.

Data from the Emirati Genome Programme will play a central role in enabling personalised interventions. The integration of genomics and AI reflects a broader healthcare strategy focused on predictive and preventive medicine.

Important Facts for Exams

Gene therapy involves modifying or replacing faulty genes to treat disease.
Beta-Propeller Protein-Associated Neurodegeneration (BPAN) is a rare inherited neurological disorder.
The Emirati Genome Programme aims to map genetic variations within the UAE population.
Precision medicine tailors treatment based on an individual’s genetic profile.

#GeneTherapy
#GeneticMedicine
#CRISPR
#GenomeEditing
#MolecularBiology
#CellAndGeneTherapy
#PrecisionMedicine
#Biotechnology
#TranslationalResearch
#RegenerativeMedicine

World Cell Biologist Awards: 

Website Link : cellbiologist.org 

Follow Us On : 
Tumblr ; tumblr.ccom/

Comments

Post a Comment

Popular posts from this blog

Uttrakhand Forest Department Establishes Mahabharata Vatika

Image
  The Uttarakhand Forest Department has established two gardens in Haldwani, showcasing plant species referenced in ancient Indian epics. These gardens, named Ramayana Vatika and Mahabharata Vatika, aim to highlight the ecological wisdom embedded in these texts. Mahabharata Vatika Overview Mahabharata Vatika spans one acre and features 37 plant species mentioned in the epic. Chief Conservator of Forests Sanjeev Chaturvedi emphasised the research behind selecting these species. The garden features important plant species such as: Ecological Significance The garden puts stress on the importance of forests as depicted in the Mahabharata. It references the Vana Parva, which discusses tree planting and wildlife conservation . The epic highlights the mutual dependence of tigers and forests, a concept vital to contemporary conservation efforts. Cultural Connections Chaturvedi brought into light that the Mahabharata teaches the spiritual significance of planting trees. He mentioned Bhish...
Read more

CAR T-Cell Therapy for Cancer

Image
  India has recently made strides in cancer treatment with the introduction of CAR T-cell therapy . The results from the first clinical trials have been published in The Lancet, showcasing a remarkable success rate. This therapy is a game changer for patients with blood cancers. It offers hope to those who have exhausted other treatment options. What is CAR T-Cell Therapy? CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative treatment that harnesses the body’s immune system. It trains T-cells to target and destroy cancer cells. This therapy is specifically designed for certain blood cancers. It is particularly beneficial for patients whose cancer has relapsed or failed to respond to standard treatments. Clinical Trial The clinical trials reported a response rate of nearly 73%. This indicates that number of patients benefited from the treatment. The trials also provided critical data on survival rates for patients with acute lymphoblastic leukaemia and l...
Read more

New Turmeric Cousin Discovered in Nagaland’s Ungma Village

Image
  During a field trip to Nagaland, researchers found a new species of plant closely related to turmeric. This new species, named Curcuma ungmensis, was discovered near the village of Ungma and has now been published in the scientific journal Phytotaxa. Taxonomy and Family Curcuma ungmensis belongs to the Curcuma genus, which is part of the ginger family, known scientifically as Zingiberaceae. This family includes about 200 species in India, such as the well-known turmeric (Curcuma longa) and black turmeric (Curcuma caesia). Plants in this genus are mainly found in South and Southeast Asia. How was the New Species Identified? Researchers carefully studied all known species of Curcuma in the region. When they couldn’t find any matches in the Checklist of Flora of Nagaland published by the Botanical Survey of India, they concluded that they had discovered a completely new species. Botanical Characteristics Curcuma ungmensis is a rhizomatous herb, meaning it grows from underground ste...
Read more